KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents
- PMID: 10816588
- DOI: 10.1074/jbc.M003245200
KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents
Abstract
KCNQ2 and KCNQ3, both of which are mutated in a type of human neonatal epilepsy, form heteromeric potassium channels that are expressed in broad regions of the brain. The associated current may be identical to the M-current, an important regulator of neuronal excitability. We now show that the RNA encoding the novel KCNQ5 channel is also expressed in brain and in sympathetic ganglia where it overlaps largely with KCNQ2 and KCNQ3. In addition, it is expressed in skeletal muscle. KCNQ5 yields currents that activate slowly with depolarization and can form heteromeric channels with KCNQ3. Currents expressed from KCNQ5 have voltage dependences and inhibitor sensitivities in common with M-currents. They are also inhibited by M1 muscarinic receptor activation. A KCNQ5 splice variant found in skeletal muscle displays altered gating kinetics. This indicates a molecular diversity of channels yielding M-type currents and suggests a role for KCNQ5 in the regulation of neuronal excitability.
Similar articles
-
Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity.J Biol Chem. 2000 Jul 21;275(29):22395-400. doi: 10.1074/jbc.M002378200. J Biol Chem. 2000. PMID: 10787416
-
Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic M channels deduced from block by tetraethylammonium.J Neurosci. 2003 Jun 15;23(12):5012-9. doi: 10.1523/JNEUROSCI.23-12-05012.2003. J Neurosci. 2003. PMID: 12832524 Free PMC article.
-
The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus.Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10232-7. doi: 10.1073/pnas.1004644107. Epub 2010 May 13. Proc Natl Acad Sci U S A. 2010. PMID: 20534576 Free PMC article.
-
KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy.Trends Neurosci. 2000 Sep;23(9):393-8. doi: 10.1016/s0166-2236(00)01629-5. Trends Neurosci. 2000. PMID: 10941184 Review.
-
M-channels: neurological diseases, neuromodulation, and drug development.Arch Neurol. 2003 Apr;60(4):496-500. doi: 10.1001/archneur.60.4.496. Arch Neurol. 2003. PMID: 12707061 Review.
Cited by
-
Pharmacological Activation of Neuronal Voltage-Gated Kv7/KCNQ/M-Channels for Potential Therapy of Epilepsy and Pain.Handb Exp Pharmacol. 2021;267:231-251. doi: 10.1007/164_2021_458. Handb Exp Pharmacol. 2021. PMID: 33837465
-
The Effects of the KCNQ Openers Retigabine and Flupirtine on Myotonia in Mammalian Skeletal Muscle Induced by a Chloride Channel Blocker.Evid Based Complement Alternat Med. 2012;2012:803082. doi: 10.1155/2012/803082. Epub 2012 Mar 25. Evid Based Complement Alternat Med. 2012. PMID: 22536291 Free PMC article.
-
Inhibition of post-synaptic Kv7/KCNQ/M channels facilitates long-term potentiation in the hippocampus.PLoS One. 2012;7(2):e30402. doi: 10.1371/journal.pone.0030402. Epub 2012 Feb 13. PLoS One. 2012. PMID: 22348007 Free PMC article.
-
KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines.Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21236-21245. doi: 10.1073/pnas.1907511116. Epub 2019 Sep 30. Proc Natl Acad Sci U S A. 2019. PMID: 31570602 Free PMC article.
-
Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent.J Neurosci. 2004 Jun 2;24(22):5079-90. doi: 10.1523/JNEUROSCI.0882-04.2004. J Neurosci. 2004. PMID: 15175377 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
